1. Schadendorf D, van Akkooi AC, Berking C, et al. Melanoma. Lancet 2018; 392: 971-984.
2.
Arnold M, Singh D, Laversanne M, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol 2022; 158: 495-503.
3.
Otmani K, Lewalle P. Tumor suppressor miRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol 2021; 11: 708765.
4.
Wozniak M, Mielczarek A, Czyz M. miRNAs in melanoma: tumor suppressors and oncogenes with prognostic potential. Curr Med Chemistry 2016; 23: 3136-3153.
5.
Latchana N, Ganju A, Howard JH, Carson III WE. MicroRNA dysregulation in melanoma. Surg Oncol 2016; 25: 184-189.
6.
Vand-Rajabpour F, Savage M, Belote RL, Judson-Torres RL. Critical considerations for investigating microRNAs during tumorigenesis: a case study in conceptual and contextual nuances of miR-211-5p in melanoma. Epigenomes 2023; 7: 9.
7.
Gajos-Michniewicz A, Czyz M. Role of miRNAs in melanoma metastasis. Cancers 2019; 11: 326.
8.
Ray A, Kunhiraman H, Perera RJ. The paradoxical behavior of microRNA-211 in melanomas and other human cancers. Front Oncol 2021; 10: 628367.
9.
Dai X, Rao C, Li H, et al. Regulation of pigmentation by micro RNA s: MITF-dependent micro RNA-211 targets TGF-ß receptor 2. Pigment Cell Melanoma Res 2015; 28: 217-222.
10.
Sun DS, Guan CH, Wang WN, Hu ZT, Zhao YQ, Jiang XM. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/ VEGF-A axis. Microvasc Res 2021; 134: 104120.
11.
Yu X, Odenthal M, Fries JW. Exosomes as miRNA carriers: formation- function-future. Int J Mol Sci 2016; 17: 2028.
12.
Ding L, Yang X, Gao Z, et al. A holistic review of the state-of the art microfluidics for exosome separation: an overview of the current status, existing obstacles, and future outlook. Small 2021; 17: 2007174.
13.
Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomed 2020; 15: 6917-6934.
14.
Chamani A, Doroudgar P, Badri K. Compared the effects of skeletal anchored maxillary protraction vs dental anchored maxillary protraction in children with class III malocclusion: a systematic review and meta-analysis. Int J Pharmaceut Res 2020; 12: 1351-1357.
15.
Li S, Xu J, Qian J, Gao X. Engineering extracellular vesicles for cancer therapy: recent advances and challenges in clinical translation. Biomaterial Sci 2020; 8: 6978-6991.
16.
Gonda A, Kabagwira J, Senthil GN, Wall NR. Internalization of exosomes through receptor-mediated endocytosis. Mol Cancer Res 2019; 17: 337-347.
17.
Seo N, Akiyoshi K, Shiku H. Exosome-mediated regulation of tumor immunology. Cancer Sci 2018; 109: 2998-3004.
18.
Hajivalili M, Baghaei K, Mosaffa N, Niknam B, Amani D. Engineering tumor-derived small extra cellular vesicles to encapsulate miR-34a, effectively inhibits 4T1 cell proliferation, migration, and gene expression. Med Oncol 2022; 39: 1-10.
19.
Zeng Q, Zhu Z, Song L, He Z. Transferred by exosomes-derived MiR- 19b-3p targets PTEN to regulate esophageal cancer cell apoptosis, migration and invasion. Biosci Rep 2020; 40: BSR20201858.
20.
Rezaei R, Baghaei K, Hashemi SM, Zali MR, Ghanbarian H, Amani D. Tumor-derived exosomes enriched by miRNA-124 promote anti-tumor immune response in CT-26 tumor-bearing mice. Front Med 2021; 8: 619939.
21.
Hosseini M, Baghaei K, Amani D, Ebtekar M. Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition. DARU J Pharmaceut Sci 2021; 29: 267-278.
22.
Zhang D, Lee H, Zhu Z, Minhas JK, Jin Y. Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 2017; 312: L110-l21.
23.
Deng X, Cao M, Zhang J, et al. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Biomaterial 2014; 35: 4333-4344.
24.
Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biol 2007; 9: 654-659.
25.
Momen-Heravi F, Bala S, Bukong T, Szabo G. Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomed 2014; 10: 1517-1527.
26.
Cheng W, Wang K, Zhao Z, et al. Exosomes-mediated transfer of miR-125a/b in cell-to-cell communication: a novel mechanism of genetic exchange in the intestinal microenvironment. Theranostics 2020; 10: 7561.
27.
Sun LH, Tian D, Yang ZC, Li JL. Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4. Sci Rep 2020; 10: 8271.
28.
Wang B, Mao JH, Wang BY, et al. Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-B signaling pathway. Cancer Lett 2020; 489: 87-99.
29.
Gonzalez MJ, Kweh MF, Biava PM, et al. Evaluation of exosome derivatives as bio-informational reprogramming therapy for cancer. J Translat Med 2021; 19: 1-10.
30.
Zhu L, Kalimuthu S, Gangadaran P, et al. Exosomes Derived from natural killer cells exert therapeutic effect in melanoma. Theranostics 2017; 7: 2732-2745.
31.
Zhou J, Yang Y, Wang W, et al. Melanoma-released exosomes directly activate the mitochondrial apoptotic pathway of CD4+ T cells through their microRNA cargo. Exp Cell Res 2018; 371: 364-371.
32.
Shen T, Huang Z, Shi C, et al. Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK-mediated endoplasmic reticulum stress. FASEB J 2020; 34: 8442-8458.
33.
Wang L, Shen Yf, Shi Zm, Shang Xj, Jin Dl, Xi F. Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thy¬roid tumor cells by downregulating SOX 11. J Clin Lab Anal 2018; 32: e22293.
34.
Chen G, Huang P, Xie J, Li R. microRNA 211 suppresses the growth and metastasis of cervical cancer by directly targeting ZEB1. Mol Med Rep 2018; 17: 1275-1282.
35.
Yarahmadi S, Abdolvahabi Z, Hesari Z, et al. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells. Gene 2019; 711: 143939.
36.
Venza I, Visalli M, Beninati C, Benfatto S, Teti D, Venza M. IL-10R-expression is post-transcriptionally regulated by miR-15a, miR- 185, and miR-211 in melanoma. BMC Med Genom 2015; 8: 1-9.
37.
Naseri Z, Oskuee RK, Jaafari MR, Forouzandeh Moghadam M. Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo. Int J Nanomed 2018; 13: 7727-7747.
38.
Chen J, Chen J, Cheng Y, et al. Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation. Stem Cell Res Ther 2020; 11: 1-13.
39.
Konishi H, Hayashi M, Taniguchi K, et al. The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy. Cancer Biol Ther 2020; 21: 1128-1135.
40.
Yao S, Yin Y, Jin G, et al. Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance. Cancer Med 2020; 9: 5989-5998.
41.
Gudbergsson, J.M. and K.B. Johnsen, Exosomes and autophagy: rekindling the vesicular waste hypothesis. J Cell Commun Signal 2019; 13: 443-450.
42.
Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012; 10: e1001450.
43.
Fane ME, Chhabra Y, Smith AG, Sturm RA. BRN 2, a POU erful driver of melanoma phenotype switching and metastasis. Pigment Cell Melanoma Res 2019; 32: 9-24.
44.
Xin N, Han M, Shi W, Kang K, Gao C. The expression of miR-211 in cutaneous melanoma and the effect of its overexpression on the proliferation and migration of A375 melanoma cells and on VEGF expression. Int J Clin Exp Med 2021; 14: 1659-1665.
45.
Levy C, Khaled M, Iliopoulos D, et al. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell 2010; 40: 841-849.